Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Condition(s):MAC Lung Disease; Treatment Refractory MAC Lung DiseaseLast Updated:February 6, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):MAC Lung Disease; Treatment Refractory MAC Lung DiseaseLast Updated:February 6, 2023Recruiting
Condition(s):Treatment-refractory SchizophreniaLast Updated:December 20, 2016Terminated
Condition(s):Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Last Updated:January 18, 2023Recruiting
Condition(s):Steroid-refractory Acute Graft-versus-Host Disease; Treatment-refractory Acute Graft-versus-Host DiseaseLast Updated:January 19, 2023Completed
Condition(s):DepressionLast Updated:June 14, 2012Completed
Condition(s):Major Depressive DisorderLast Updated:April 8, 2021Completed
Condition(s):Colorectal CancerLast Updated:February 18, 2019Unknown status
Condition(s):Multiple SclerosisLast Updated:March 11, 2014Unknown status
Condition(s):Breast Cancer; Pancreas Cancer; Prostate Cancer; Lung Cancer; Colon Cancer; Esophagus Cancer; Liver Cancer; Ovary Cancer; Advanced or Metastatic Treatment-refractory Solid Tumor MalignanciesLast Updated:December 22, 2020Completed
Condition(s):Major Depressive DisorderLast Updated:October 20, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.